IMUNON, INC. — Cash Flow Charts
9 years of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-228.0% -$16M
$-23M
Free Cash Flow↓-225.4% -$16M
$-23M
Investing Cash Flow↑+607.3% +$10M
$8M
Financing Cash Flow↓-36.5% -$4M
$7M
Capex↑+93.5% +$129K
$268K
Acquisitions
$3M
Stock-Based Comp↓-41.9% -$2M
$3M
Debt Issued
$1M
Debt Repaid
$1M
D&A↓-44.8% -$160K
$197K
SBC Allocated Expense↓-41.9% -$2M
$3M
SBC Unrecognized Cost
$700K